Uveal Diseases
Welcome,         Profile    Billing    Logout  
 73 Companies   93 Products   93 Products   71 Mechanisms of Action   2 Trials   376 News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Uveal Diseases
NCT01338389: Influence of Oral Treatment with Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas with Proton Beam Therapy

Completed
N/A
21
Europe
CITICOLINE, PLACEBO
Centre Hospitalier Universitaire de Nice, DENSMORE pharmaceuticals
Uveal Melanoma
06/17
06/17
NCT00872391: Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma

Recruiting
N/A
155
Europe
Hypofractionated linear accelerator radiotherapy
Medical University of Vienna
Uveal Melanoma
03/24
 
NCT01438658: Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma

Recruiting
N/A
250
RoW
Hadassah Medical Organization
Uveal Melanoma
12/40
12/40
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Uveal Diseases
NCT01338389: Influence of Oral Treatment with Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas with Proton Beam Therapy

Completed
N/A
21
Europe
CITICOLINE, PLACEBO
Centre Hospitalier Universitaire de Nice, DENSMORE pharmaceuticals
Uveal Melanoma
06/17
06/17
NCT00872391: Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma

Recruiting
N/A
155
Europe
Hypofractionated linear accelerator radiotherapy
Medical University of Vienna
Uveal Melanoma
03/24
 
NCT01438658: Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma

Recruiting
N/A
250
RoW
Hadassah Medical Organization
Uveal Melanoma
12/40
12/40

Download Options